Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Budesonide Capsules Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Entocort Capsules
  • 1.3.3 Generic of Entocort
• 1.4 Market Segment by Application
  • 1.4.1 Global Budesonide Capsules Market Share by Application (2019-2025)
  • 1.4.2 Crohn's disease
  • 1.4.3 Collagenous colitis
  • 1.4.4 Autoimmune hepatitis
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Budesonide Capsules Market Size
  • 2.1.1 Global Budesonide Capsules Revenue 2014-2025
  • 2.1.2 Global Budesonide Capsules Sales 2014-2025
• 2.2 Budesonide Capsules Growth Rate by Regions
  • 2.2.1 Global Budesonide Capsules Sales by Regions 2014-2019
  • 2.2.2 Global Budesonide Capsules Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Budesonide Capsules Sales by Manufacturers
  • 3.1.1 Budesonide Capsules Sales by Manufacturers 2014-2019
  • 3.1.2 Budesonide Capsules Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Budesonide Capsules Revenue by Manufacturers (2014-2019)
  • 3.2.2 Budesonide Capsules Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Budesonide Capsules Market Concentration Ratio (CR5 and HHI)
• 3.3 Budesonide Capsules Price by Manufacturers
• 3.4 Key Manufacturers Budesonide Capsules Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Budesonide Capsules Market
• 3.6 Key Manufacturers Budesonide Capsules Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Entocort Capsules Sales and Revenue (2014-2019)
  • 4.1.2 Generic of Entocort Sales and Revenue (2014-2019)
• 4.2 Global Budesonide Capsules Sales Market Share by Type
• 4.3 Global Budesonide Capsules Revenue Market Share by Type
• 4.4 Budesonide Capsules Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Budesonide Capsules Sales by Application

6 United States

• 6.1 United States Budesonide Capsules Breakdown Data by Company
• 6.2 United States Budesonide Capsules Breakdown Data by Type
• 6.3 United States Budesonide Capsules Breakdown Data by Application

7 European Union

• 7.1 European Union Budesonide Capsules Breakdown Data by Company
• 7.2 European Union Budesonide Capsules Breakdown Data by Type
• 7.3 European Union Budesonide Capsules Breakdown Data by Application

8 China

• 8.1 China Budesonide Capsules Breakdown Data by Company
• 8.2 China Budesonide Capsules Breakdown Data by Type
• 8.3 China Budesonide Capsules Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Budesonide Capsules Breakdown Data by Company
• 9.2 Rest of World Budesonide Capsules Breakdown Data by Type
• 9.3 Rest of World Budesonide Capsules Breakdown Data by Application
• 9.4 Rest of World Budesonide Capsules Breakdown Data by Countries
  • 9.4.1 Rest of World Budesonide Capsules Sales by Countries
  • 9.4.2 Rest of World Budesonide Capsules Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Perrigo
  • 10.1.1 Perrigo Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Budesonide Capsules
  • 10.1.4 Budesonide Capsules Product Introduction
  • 10.1.5 Perrigo Recent Development
• 10.2 Mylan
  • 10.2.1 Mylan Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Budesonide Capsules
  • 10.2.4 Budesonide Capsules Product Introduction
  • 10.2.5 Mylan Recent Development
• 10.3 Tillotts Pharma
  • 10.3.1 Tillotts Pharma Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Budesonide Capsules
  • 10.3.4 Budesonide Capsules Product Introduction
  • 10.3.5 Tillotts Pharma Recent Development
• 10.4 Teva
  • 10.4.1 Teva Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Budesonide Capsules
  • 10.4.4 Budesonide Capsules Product Introduction
  • 10.4.5 Teva Recent Development
• 10.5 Zydus Pharmaceuticals
  • 10.5.1 Zydus Pharmaceuticals Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Budesonide Capsules
  • 10.5.4 Budesonide Capsules Product Introduction
  • 10.5.5 Zydus Pharmaceuticals Recent Development
• 10.6 Amneal
  • 10.6.1 Amneal Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Budesonide Capsules
  • 10.6.4 Budesonide Capsules Product Introduction
  • 10.6.5 Amneal Recent Development
• 10.7 Mayne Pharma
  • 10.7.1 Mayne Pharma Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Budesonide Capsules
  • 10.7.4 Budesonide Capsules Product Introduction
  • 10.7.5 Mayne Pharma Recent Development
• 10.8 Sciecure Pharma
  • 10.8.1 Sciecure Pharma Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Budesonide Capsules
  • 10.8.4 Budesonide Capsules Product Introduction
  • 10.8.5 Sciecure Pharma Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Budesonide Capsules Sales Channels
  • 11.2.2 Budesonide Capsules Distributors
• 11.3 Budesonide Capsules Customers

12 Market Forecast

• 12.1 Global Budesonide Capsules Sales and Revenue Forecast 2019-2025
• 12.2 Global Budesonide Capsules Sales Forecast by Type
• 12.3 Global Budesonide Capsules Sales Forecast by Application
• 12.4 Budesonide Capsules Forecast by Regions
  • 12.4.1 Global Budesonide Capsules Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Budesonide Capsules Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
In 2019, the market size of Budesonide Capsules is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Budesonide Capsules.

This report studies the global market size of Budesonide Capsules, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Budesonide Capsules sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma

Market Segment by Product Type
Entocort Capsules
Generic of Entocort

Market Segment by Application
Crohn's disease
Collagenous colitis
Autoimmune hepatitis

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Budesonide Capsules status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Budesonide Capsules manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Budesonide Capsules are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025